relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
Published 1 year ago • 237 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
3:29
gynecologic oncology at esmo congress 2021: relacorilant, a phase 2 study
-
59:55
tackling platinum resistant ovarian cancer
-
1:41
unmet clinical needs for platinum-resistant ovarian cancer patients
-
9:05
case 4: recurrent ovarian cancer, platinum-resistant, brca wt
-
1:10
rebastinib and paclitaxel for advanced/metastatic ovarian cancer
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
1:13
predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc
-
3:51
achieving a higher pcr rate with nab-paclitaxel in breast cancer
-
3:56
treatment ovarian cancer with novel targeted therapies and io
-
2:20
nab-paclitaxel does not extend survival in biliary tract cancer; though has benefits for some
-
0:41
liquid biopsy: monitoring recurrence in high-risk ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:41
dr. konner on preferred platinum doublets in recurrent ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
5:27
recurrent ovarian cancer; considerations beyond the platinum-free interval
-
9:08
factors in choice of treatment for recurrent ovarian cancer